Literature DB >> 11009185

Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease.

J H Bower1, D M Maraganore, S K McDonnell, W A Rocca.   

Abstract

We studied the influence of three sets of diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease (PD) among residents of Olmsted County, Minnesota, for the period 1976 to 1990. Incidence cases of parkinsonism were detected using the medical records-linkage system of the Rochester Epidemiology Project. PD was separated from other types of parkinsonism using strict, intermediate, and broad criteria. We found 154 incident cases of PD using the strict criteria, 215 using the intermediate criteria, and 266 using the broad criteria. The incidence rate was consistently higher for men across all ages with all three sets of criteria; however, sex differences were more striking at older ages when using the broad criteria. In men above age 79 years, the incidence rate of PD declined with strict criteria, remained stable with intermediate criteria, and increased with broad criteria. The impact of diagnostic criteria on the age-specific incidence curve was less striking for women. When using the broad criteria, the risk of PD increased constantly with age in both sexes, suggesting that PD is an aging-related disease. Our findings suggest that the diagnostic criteria used to separate PD from other types of parkinsonism influence the magnitude of PD incidence and its distribution by age and sex.

Entities:  

Mesh:

Year:  2000        PMID: 11009185     DOI: 10.1002/1531-8257(200009)15:5<819::aid-mds1009>3.0.co;2-p

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

Review 2.  Axon degeneration in Parkinson's disease.

Authors:  Robert E Burke; Karen O'Malley
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

3.  Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease.

Authors:  Vincent Ries; Claire Henchcliffe; Tatyana Kareva; Margarita Rzhetskaya; Ross Bland; Matthew J During; Nikolai Kholodilov; Robert E Burke
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

Review 4.  Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease.

Authors:  Robert E Burke
Journal:  Pharmacol Ther       Date:  2007-02-27       Impact factor: 12.310

Review 5.  Neurodegeneration and neuroprotection in Parkinson disease.

Authors:  Stanley Fahn; David Sulzer
Journal:  NeuroRx       Date:  2004-01

6.  Dopamine content in the striatum and expression changes of Bad and Bcl-2 in elderly rats with abnormal behavior.

Authors:  Zheng-Quan Yu; Mei-Ying Liu; Qing-Xian Ren; Ye Xiong; Jian-Hui Xu; Cheng-Hua Xiao; Dian-Shuai Gao
Journal:  Neurochem Res       Date:  2011-08-05       Impact factor: 3.996

7.  Common variants in PARK loci and related genes and Parkinson's disease.

Authors:  Sun Ju Chung; Sebastian M Armasu; Joanna M Biernacka; Timothy G Lesnick; David N Rider; Sarah J Lincoln; Alexandra I Ortolaza; Matthew J Farrer; Julie M Cunningham; Walter A Rocca; Demetrius M Maraganore
Journal:  Mov Disord       Date:  2010-12-13       Impact factor: 10.338

8.  The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy.

Authors:  Kurt Kimpinski; Valeria Iodice; Duane D Burton; Michael Camilleri; Brian P Mullan; Axel Lipp; Paola Sandroni; Tonette L Gehrking; David M Sletten; J E Ahlskog; Robert D Fealey; Wolfgang Singer; Phillip A Low
Journal:  J Neurol Sci       Date:  2012-03-14       Impact factor: 3.181

9.  Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers.

Authors:  Adina L Feldman; Anna L V Johansson; Margaret Gatz; Måns Flensburg; Giselle M Petzinger; Håkan Widner; Mark F Lew; Nancy L Pedersen; Karin Wirdefeldt
Journal:  Neuroepidemiology       Date:  2012-03-29       Impact factor: 3.282

10.  Incidence and remaining lifetime risk of Parkinson disease in advanced age.

Authors:  Jane A Driver; Giancarlo Logroscino; J Michael Gaziano; Tobias Kurth
Journal:  Neurology       Date:  2009-02-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.